Shopping Cart
Your Cart is Empty
There was an error with PayPalClick here to try again
CelebrateThank you for your business!You should be receiving an order confirmation from Paypal shortly.Exit Shopping Cart

Saturday, March 26, 2022

Becoming A Psychedelic-Informed Clinician

Date: Saturday, March 26, 2022

Time: 9a-5pm (Program)

Type: Live Webinar

Credits: 7 CEUs (NY​S LMSWs, LCSWs, LMHCs, LMFTs, Psychologists)

Location: Zoom

Instructor: Peter H Addy, PhD

Cost: $ 199 Individual, $ 140 Early Bird (register by 2/25/22), $120 Super Saver (register by 1/25/22), 

$75 Grad Students,

$99 3+ Group Rate (each, same organization)

[*Larger groups (same organization) – call for Special Rates*]


Your clients are using psilocybin mushrooms, “ecstasy”, ayahuasca, and other psychedelic substances at increasing rates. Academic and corporate researchers are investigating these same substances as breakthrough medicines to heal trauma, depression, substance use, and other debilitating conditions. Learn the truth about these controversial medicines and their history. Become a psychedelic-informed clinician so that your clients can talk about their experiences and intentions without fear of judgement or pathologizing. Help them identify risks as well as how their psychedelic use may align with your treatment outcomes.


1. Understand who is likely to use psychedelics and why in order to better identify client use and understand their use in context

2. Differentiate between different categories of psychedelics to better assess risks and improve treatment outcomes

3. Evaluate the current legal landscape in order to help clients have true informed consent for their use and to provide information on legal options, when available

4. Assess clients for potential harm and understand contraindications and differential diagnoses that may impact treatment

5. Practice psychedelic-informed treatment in order to support your clients in their goals


Peter H Addy, PhD, LPC, LMHC, has studied psychedelic substances and states and consciousness for 15 years. He earned a PhD in clinical psychology studying transcendence, wholeness, and transformation and conducted one of the earliest studies of the atypical psychedelic plant Salvia divinorum in humans. He continued refining his research and clinical skills at Yale University where he studied Salvia and other atypical psychedelics and co-founded the Yale Psychedelic Science Group. He has completed postdoctoral training in substance use disorder treatment, participated in non-directive harm reduction and integration training at Burning Man, and traveled to Mexico to learn about indigenous use of psychedelic plants among the Mazatec people.

He is currently a psychotherapist in private practice in Washington and Oregon.

Dr. Addy has presented internationally on a variety of subjects related to spirituality and transpersonal states, psychedelic science, and research methodology. Participants consistently regarded his talks as informative, accessible, and humorous. He has written numerous scientific articles, book chapters, and popular press articles on typical and atypical psychedelics, substance abuse, and spirituality.

Register Now

At Counseling Services of Long Island, our goal is to help you stay updated with the latest research, theories, and techniques in the industry.

Enroll now and join an elite group of your peers.